Duker Sees “Energy” Being Added to Gene Therapy Field
Jay Duker, MD, Director of the New England Eye Center and Chairman of Ophthalmology at Tufts Medical Center and the Tufts University School of Medicine, tells OISTV the approval of gene therapy products including Spark Therapeutics’ SPK-RPE65 would help the sector clear a “real and psychological” hurdle facing gene therapy companies.
Speaking With:
Jay Duker, MD
Jay S. Duker, MD, is the Director of the New England Eye Center, Professor and Chairman of Ophthalmology at Tufts Medical Center and the Tufts University School of Medicine.